POGO's Staff Scientist Says New Doctor Rules Promote TransparencyTweet
February 12, 2013
New disclosure rules for doctors on advisory panels for the Food and Drug Administration are meant to increase transparency without discouraging doctors from serving on the panels, according to Ned Feder, the Project On Government Oversight's staff scientist. Feder was on Public News Service to discuss new rules for drug companies and medical device makers as part of the Affordable Care Act. \
According to Feder, increased transparency should help identify conflicts of interest among doctors who have a financial stake in drugs or devices they evaluate.
It's hard to imagine that a person receiving this kind of payment will maintain complete objectivity over the value of the drug, its safety and its effectiveness.
You can listen to the segment by clicking here.
Andre Francisco is the Online Producer for the Project On Government Oversight.
Topics: Public Health and Science
Authors: Andre Francisco
- August 8, 2017
- August 3, 2017
- July 21, 2017
- June 20, 2017
- June 8, 2017
- June 1, 2017
- May 18, 2017
- April 6, 2017